Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails.

Macmadu A, Goedel WC, Adams JW, Brinkley-Rubinstein L, Green TC, Clarke JG, Martin RA, Rich JD, Marshall BDL.

Drug Alcohol Depend. 2020 Jan 18;208:107858. doi: 10.1016/j.drugalcdep.2020.107858. [Epub ahead of print]

PMID:
32050112
2.

Pharmacy leaders' beliefs about how pharmacies can support a sustainable approach to providing naloxone to the community.

Donovan E, Bratberg J, Baird J, Burstein D, Case P, Walley AY, Green TC.

Res Social Adm Pharm. 2020 Jan 18. pii: S1551-7411(19)30590-X. doi: 10.1016/j.sapharm.2020.01.006. [Epub ahead of print]

PMID:
31983625
3.

An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.

Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, Clarke W, Sherman SG.

Int J Drug Policy. 2020 Jan 14;77:102661. doi: 10.1016/j.drugpo.2020.102661. [Epub ahead of print]

4.

Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study.

Burstein D, Baird J, Bratberg J, Donovan E, Soipe A, Tapper A, Case P, Walley AY, Green TC.

J Am Pharm Assoc (2003). 2019 Dec 20. pii: S1544-3191(19)30510-2. doi: 10.1016/j.japh.2019.11.004. [Epub ahead of print]

PMID:
31870862
5.

Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy.

Green TC, Bratberg J, Baird J, Burstein D, Lenz K, Case P, Walley AY, Xuan Z.

Int J Drug Policy. 2019 Nov 15:102602. doi: 10.1016/j.drugpo.2019.11.010. [Epub ahead of print]

PMID:
31740174
6.

Multidisciplinary Team Reviews of Drug Overdose Deaths and the Use of Minigrants to Advance Recommendations: A Statewide Pilot in Rhode Island.

Hackman HH, Koziol JA, McCormick M, McDonald JV, Green TC.

J Public Health Manag Pract. 2019 Oct 31. doi: 10.1097/PHH.0000000000001081. [Epub ahead of print]

PMID:
31688739
7.

Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians.

Kurian S, Baloy B, Baird J, Burstein D, Xuan Z, Bratberg J, Tapper A, Walley A, Green TC.

J Am Pharm Assoc (2003). 2019 Nov - Dec;59(6):824-831. doi: 10.1016/j.japh.2019.08.009. Epub 2019 Sep 30.

PMID:
31582224
8.

The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015.

Walley AY, Bernson D, Larochelle MR, Green TC, Young L, Land T.

Public Health Rep. 2019 Nov/Dec;134(6):667-674. doi: 10.1177/0033354919878429. Epub 2019 Oct 2.

PMID:
31577519
9.

Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities.

Morales KB, Park JN, Glick JL, Rouhani S, Green TC, Sherman SG.

Drug Alcohol Depend. 2019 Nov 1;204:107547. doi: 10.1016/j.drugalcdep.2019.107547. Epub 2019 Aug 23.

10.

Evaluation of a Safer Opioid Prescribing Protocol (SOPP) for Patients Being Discharged From a Trauma Service.

Baird J, Faul M, Green TC, Howland J, Adams CA Jr, Hodne MJ, Bohlen N, Mello MJ.

J Trauma Nurs. 2019 May/Jun;26(3):113-120. doi: 10.1097/JTN.0000000000000435.

PMID:
31483766
11.

Prevalence and Correlates of Depressive Symptomology among Young Adults Who Use Prescription Opioids Non-medically.

Bouvier BA, Kinnard EN, Yedinak JL, Li Y, Elston B, Green TC, Hadland SE, Marshall BDL.

J Psychoactive Drugs. 2019 Nov-Dec;51(5):441-452. doi: 10.1080/02791072.2019.1654151. Epub 2019 Aug 14.

PMID:
31411548
12.

Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.

Rouhani S, Park JN, Morales KB, Green TC, Sherman SG.

Harm Reduct J. 2019 Jun 24;16(1):39. doi: 10.1186/s12954-019-0311-9.

13.

Suspected involvement of fentanyl in prior overdoses and engagement in harm reduction practices among young adults who use drugs.

Goldman JE, Krieger MS, Buxton JA, Lysyshyn M, Sherman SG, Green TC, Bernstein E, Hadland SE, Marshall BDL.

Subst Abus. 2019;40(4):519-526. doi: 10.1080/08897077.2019.1616245. Epub 2019 Jun 17.

PMID:
31206354
14.

Increased Risk of Opioid Overdose Death Following Cold Weather: A Case-Crossover Study.

Goedel WC, Marshall BDL, Spangler KR, Alexander-Scott N, Green TC, Wellenius GA, Weinberger KR.

Epidemiology. 2019 Sep;30(5):637-641. doi: 10.1097/EDE.0000000000001041.

PMID:
31205291
15.

Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston.

Park JN, Sherman SG, Rouhani S, Morales KB, McKenzie M, Allen ST, Marshall BDL, Green TC.

J Urban Health. 2019 Jun;96(3):353-366. doi: 10.1007/s11524-019-00365-1.

PMID:
31168735
16.

High-dose prescribed opioids are associated with increased risk of heroin use among United States military veterans.

Banerjee G, Edelman EJ, Barry DT, Crystal S, Gordon KS, Gordon AJ, Gaither JR, Green TC, Kerns RD, Manhapra A, Moore BA, Fiellin DA, Marshall BDL.

Pain. 2019 Sep;160(9):2126-2135. doi: 10.1097/j.pain.0000000000001606.

PMID:
31145217
17.

"One guy goes to jail, two people are ready to take his spot": Perspectives on drug-induced homicide laws among incarcerated individuals.

Peterson M, Rich J, Macmadu A, Truong AQ, Green TC, Beletsky L, Pognon K, Brinkley-Rubinstein L.

Int J Drug Policy. 2019 Aug;70:47-53. doi: 10.1016/j.drugpo.2019.05.001. Epub 2019 May 10.

PMID:
31082662
18.

Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.

Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC.

Int J Drug Policy. 2019 Jun;68:46-53. doi: 10.1016/j.drugpo.2019.03.003. Epub 2019 Apr 13.

19.

Increased overdose mortality during the first week of the month: Revisiting the "check effect" through a spatial lens.

Goedel WC, Green TC, Viner-Brown S, Rich JD, Marshall BDL.

Drug Alcohol Depend. 2019 Apr 1;197:49-55. doi: 10.1016/j.drugalcdep.2018.12.024. Epub 2019 Feb 12.

PMID:
30776571
20.

Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.

Donovan E, Case P, Bratberg JP, Baird J, Burstein D, Walley AY, Green TC.

J Urban Health. 2019 Jun;96(3):367-378. doi: 10.1007/s11524-019-00349-1.

PMID:
30747371
21.

Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study.

Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG.

Drug Alcohol Depend. 2019 Jan 1;194:527-532. doi: 10.1016/j.drugalcdep.2018.10.017. Epub 2018 Nov 13.

PMID:
30551090
22.

How the Comprehensive Cancer Control National Partnership shapes the public health workforce.

Farrell MM, Gibson KM, Marler A, Given L, Van Kirk Villalobos A, Maynard CD, Bright FS, Kirklin GT, Green TC, Ruhe M, Thorsness J, Weiss S.

Cancer Causes Control. 2018 Dec;29(12):1205-1220. doi: 10.1007/s10552-018-1110-4. Epub 2018 Dec 6.

23.

Use of rapid fentanyl test strips among young adults who use drugs.

Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, Rich JD, Hadland SE, Green TC, Marshall BDL.

Int J Drug Policy. 2018 Nov;61:52-58. doi: 10.1016/j.drugpo.2018.09.009. Epub 2018 Oct 18.

24.

Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months.

Stone AC, Carroll JJ, Rich JD, Green TC.

Drug Alcohol Depend. 2018 Nov 1;192:94-97. doi: 10.1016/j.drugalcdep.2018.07.019. Epub 2018 Aug 25.

PMID:
30243145
25.

The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible.

Carroll JJ, Rich JD, Green TC.

J Addict Med. 2018 Nov/Dec;12(6):459-465. doi: 10.1097/ADM.0000000000000436.

26.

Status of US State Laws Mandating Timely Reporting of Nonfatal Overdose.

Davis CS, Green TC, Hernandez-Delgado H, Lieberman AJ.

Am J Public Health. 2018 Sep;108(9):1159-1161. doi: 10.2105/AJPH.2018.304589. No abstract available.

PMID:
30088991
27.

Commentary on 'Revisiting the 'paradigm shift' in opioid use: Developments and implications 10 years later'.

Green TC, Rich JD, Sharfstein J.

Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S206-S207. doi: 10.1111/dar.12684. Epub 2018 Feb 26. No abstract available.

PMID:
29479758
28.

Risk of fentanyl-involved overdose among those with past year incarceration: Findings from a recent outbreak in 2014 and 2015.

Brinkley-Rubinstein L, Macmadu A, Marshall BDL, Heise A, Ranapurwala SI, Rich JD, Green TC.

Drug Alcohol Depend. 2018 Apr 1;185:189-191. doi: 10.1016/j.drugalcdep.2017.12.014. Epub 2018 Feb 9.

PMID:
29459328
29.

Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.

Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BDL, Alexander-Scott N, Boss R, Rich JD.

JAMA Psychiatry. 2018 Apr 1;75(4):405-407. doi: 10.1001/jamapsychiatry.2017.4614. No abstract available.

30.

High willingness to use rapid fentanyl test strips among young adults who use drugs.

Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, Green TC, Hadland SE, Marshall BDL.

Harm Reduct J. 2018 Feb 8;15(1):7. doi: 10.1186/s12954-018-0213-2.

31.

Reducing Collateral Damage in Responses to the Opioid Crisis.

Carroll JJ, Rich JD, Green TC.

Am J Public Health. 2018 Mar;108(3):349-350. doi: 10.2105/AJPH.2017.304270. No abstract available.

PMID:
29412724
32.

The Effectiveness of Internet- and Field-Based Methods to Recruit Young Adults Who Use Prescription Opioids Nonmedically.

Marshall BDL, Green TC, Elston B, Yedinak JL, Hadland SE, Clark MA.

Subst Use Misuse. 2018 Aug 24;53(10):1688-1699. doi: 10.1080/10826084.2018.1425725. Epub 2018 Jan 24.

33.

Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically.

Bouvier BA, Waye KM, Elston B, Hadland SE, Green TC, Marshall BDL.

Drug Alcohol Depend. 2018 Feb 1;183:73-77. doi: 10.1016/j.drugalcdep.2017.10.023. Epub 2017 Dec 7.

34.

Prevalence of Hepatitis C Screening, Testing, and Care Experience Among Young Adults Who Use Prescription Opioids Nonmedically.

Soipe AI, Taylor LE, Abioye AI, Green TC, Hadland SE, Marshall BDL.

J Adolesc Health. 2018 Jan;62(1):114-117. doi: 10.1016/j.jadohealth.2017.07.018. Epub 2017 Oct 25.

35.

Development of a Statewide, Publicly Accessible Drug Overdose Surveillance and Information System.

Marshall BDL, Yedinak JL, Goyer J, Green TC, Koziol JA, Alexander-Scott N.

Am J Public Health. 2017 Nov;107(11):1760-1763. doi: 10.2105/AJPH.2017.304007. Epub 2017 Sep 21.

36.

Injection drug use and overdose among young adults who use prescription opioids non-medically.

Liebling EJ, Green TC, Hadland SE, Marshall BDL.

Addict Behav. 2018 Jan;76:20-26. doi: 10.1016/j.addbeh.2017.07.017. Epub 2017 Jul 18.

37.

A retrospective review of unintentional opioid overdose risk and mitigating factors among acutely injured trauma patients.

Baird J, Faul M, Green TC, Howland J, Adams CA, George A, Mello MJ.

Drug Alcohol Depend. 2017 Sep 1;178:130-135. doi: 10.1016/j.drugalcdep.2017.04.030. Epub 2017 Jun 13.

38.

Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA.

Marshall BDL, Krieger MS, Yedinak JL, Ogera P, Banerjee P, Alexander-Scott NE, Rich JD, Green TC.

Int J Drug Policy. 2017 Aug;46:130-135. doi: 10.1016/j.drugpo.2017.05.029. Epub 2017 Jun 7. No abstract available.

PMID:
28601512
39.

Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.

Carroll JJ, Marshall BDL, Rich JD, Green TC.

Int J Drug Policy. 2017 Aug;46:136-145. doi: 10.1016/j.drugpo.2017.05.023. Epub 2017 Jun 1.

40.

A mapping review of take-home naloxone for people released from correctional settings.

Horton M, McDonald R, Green TC, Nielsen S, Strang J, Degenhardt L, Larney S.

Int J Drug Policy. 2017 Aug;46:7-16. doi: 10.1016/j.drugpo.2017.05.015. Epub 2017 May 30. Review.

PMID:
28575724
41.

Associations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis.

Evans TI, Liebling EJ, Green TC, Hadland SE, Clark MA, Marshall BDL.

J Addict Med. 2017 Jul/Aug;11(4):266-272. doi: 10.1097/ADM.0000000000000318.

42.

Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016.

Somerville NJ, O'Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, Ruiz S, Babakhanlou-Chase H, Chan M, Callis BP, Kuramoto-Crawford J, Nields HM, Walley AY.

MMWR Morb Mortal Wkly Rep. 2017 Apr 14;66(14):382-386. doi: 10.15585/mmwr.mm6614a2.

43.

Beliefs About a Complementary and Alternative Therapy-Based Chronic Pain Management Program for a Medicaid Population.

Donovan E, Ranney ML, Patry EJ, McKenzie M, Baird J, Green TC.

Pain Med. 2017 Sep 1;18(9):1805-1816. doi: 10.1093/pm/pnx051.

PMID:
28398544
44.

Correlation of digital health use and chronic pain coping strategies.

Ranney ML, Duarte C, Baird J, Patry EJ, Green TC.

Mhealth. 2016 Sep 6;2:35. doi: 10.21037/mhealth.2016.08.05. eCollection 2016.

45.

Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.

Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD.

Harm Reduct J. 2017 Feb 20;14(1):13. doi: 10.1186/s12954-017-0139-0.

46.

Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.

Green TC, Case P, Fiske H, Baird J, Cabral S, Burstein D, Schwartz V, Potter N, Walley AY, Bratberg J.

J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2S):S19-S27.e4. doi: 10.1016/j.japh.2017.01.013. Epub 2017 Feb 14.

PMID:
28214219
47.

Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Stopka TJ, Donahue A, Hutcheson M, Green TC.

J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2S):S34-S44. doi: 10.1016/j.japh.2016.12.077. Epub 2017 Feb 8.

48.

Detecting naloxone prejudices in the pharmacy setting.

Green TC, Potter N, Bratberg J; MOON Study (Maximizing Opioid Safety with Naloxone).

J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2S):S10-S11. doi: 10.1016/j.japh.2016.12.068. Epub 2017 Jan 31. No abstract available.

PMID:
28159504
49.

Chronic Pain in the Emergency Department.

Donovan E, Ranney ML, Reid AM, Baird J, Green TC.

R I Med J (2013). 2017 Feb 1;100(2):25-29.

PMID:
28146596
50.

Patient Simulation for Assessment of Layperson Management of Opioid Overdose With Intranasal Naloxone in a Recently Released Prisoner Cohort.

Kobayashi L, Green TC, Bowman SE, Ray MC, McKenzie MS, Rich JD.

Simul Healthc. 2017 Feb;12(1):22-27. doi: 10.1097/SIH.0000000000000182.

Supplemental Content

Loading ...
Support Center